This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.

Catalyst for a Cure Research Progress: Biomarker Initiative

Glaucoma Research Foundation established the Catalyst for a Cure Biomarker Initiative to help glaucoma patients preserve their vision.

Using Cataract Surgery to Treat Glaucoma Could Be the Next Step to a More Effective Treatment for PCAG

There is evidence that the lens extraction and replacement method used for cataract treatment may be a viable option for primary closed-angle glaucoma as well.

New Research Can Help Find Solutions to the Challenge of Glaucoma in Developing Countries

Glaucoma in developing countries represents a significant health crisis.

New Research Suggests A Breakthrough In Understanding Normal Tension Glaucoma

Researchers are still in the early stages of exploring how this information can be turned into new glaucoma treatments.

Dr. Tonia Rex Leads the Way with EPO Treatments That Fight Optic Nerve Degeneration from Glaucoma

“I am a researcher because I am driven to understand disease in order to treat it and be able to help people.” – Tonia Rex, PhD

Biomarkers and Drug Discovery: Jeffrey L. Goldberg, MD, PhD

Dr. Goldberg talks about the Catalyst for a Biomarker Imitative and its impact on glaucoma research.

Dr. Jeffrey Goldberg Discusses Glaucoma Research Foundation’s Catalyst for a Cure and a New Surgical Implant Option for Patients

Dr. Goldberg’s research is directed at neuroprotection and regeneration of retinal ganglion cells and the optic nerve, as well as stem cell and nanotherapeutic approaches to repair damaged eyes.

Easier Glaucoma Diagnosis with Smartphone Apps and Artificial Intelligence

Researchers are working on some amazing things that artificial intelligence (AI) can do for glaucoma sufferers, especially in the areas of diagnosis and disease management, but it will take time and more work.

Discovering Matrix Metalloproteinases and How They Could Lead to Future Glaucoma Treatments

Matrix metalloproteinases (or MMPs) may sound like something out of a sci-fi story, but they’re a real-life family of enzymes—the metzincin superfamily—that thrive inside the human body.

Restoring Peripheral Vision to Glaucoma Patients with Prism Glasses

Researchers are developing a new type of glasses that contain a prism that will redirect the sight of a person with limited peripheral vision.

Optic Nerve Regeneration

Glaucoma causes damage to the optic nerve, which can result in an eventual loss of vision.

Dr. Andrew Huberman: What Motivates Me as a Scientist

“What motivates me is the very real possibility of discovering something in my laboratory that can allow patients to see to see much better, for much longer periods of their life, and maybe even reverse blindness.”

Research On Retinal Pigment Epithelial (RPE) Cells Promises New Future Treatment for Glaucoma Patients

Glaucoma doesn’t typically damage RPE cells, but thanks to advances in stem cell research, it looks like RPE cells may play a crucial role in finding a cure to the degenerative disease.

Powerful, Transformative Research: An Interview with Shaffer Prize Winner Dr. Richard Libby

We are honored to introduce you to a prominent researcher whose work in glaucoma may one day lead to a cure: Dr. Richard Libby.

A Timeline for Glaucoma Therapy Development: Reality and Risks Of Pharmaceutical Research

No one can predict the next big breakthrough in glaucoma treatment, but one thing is certain: A whole lot of experts are searching for ways to make the future better.

GRF Scientific Advisors discuss the Importance of Biomarkers for Glaucoma

Catalyst for a Cure (CFC) is a collaborative team of investigators funded by Glaucoma Research Foundation.

Occupational Therapy Training Helps Low Vision Patients

In an attempt to demonstrate that low vision patients have good potential for overcoming vision loss, researchers undertook a study and presented their findings.

Working Together to Find Biomarkers for Glaucoma Means Lower Risk of Vision Loss

With exciting new biomarkers on the horizon, this is a good time to learn more about what they are and how they’ll ultimately help find a cure for glaucoma.

Promising New Procedure Targets Vascular Changes to Diagnose Glaucoma Early

While this is a major breakthrough, OCT angiography must be improved before it will be ready for use in your doctor’s office.

Could Cataract Surgery Be A New Treatment Option for Primary Closed-Angle Glaucoma?

Data published in October 2016 shows there is a successful, safe, routine surgical procedure that has been restoring eyesight for ages, and it may be the answer to treating primary closed-angle glaucoma (PCAG).

Glaucoma Biomarkers: from the Laboratory to the Clinic

Catalyst for a Cure researchers have been taking necessary steps to move their studies from the laboratory to the clinic.

New Nitric Oxide Medication to Reduce Intraocular Pressure Takes on Glaucoma from a New Angle

Nitric oxide has become a popular dietary supplement because it can help improve blood flow and lower blood pressure. As it turns out, nitric oxide also works as a glaucoma treatment.

Science Fiction May Hint at Vision-Restoring Prostheses for Glaucoma Patients

Researchers are developing and validating new technologies that could enable less invasive approaches for vision prosthetics.

Newly Funded Research Promoting Retinal Cell Axon Regeneration is Underway Thanks to NEI’s Audacious Goals Initiative

Optic nerve regeneration could be the answer to curing glaucoma, or at least substantially slowing the progression of the disease.

Why Induced Pluripotent Stem Cells Are Vital for Glaucoma Research and Treatments

Stem cells are poised to make an impact on glaucoma research and treatment, as adult stem cells can be taken from the eye or skin, and used to try to replace damaged cells in your eye.